KAYNE RICHARD A 13D/13G Filings for Athira Pharma, Inc. (ATHA)

KAYNE RICHARD A 13D and 13G filings for Athira Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-04-20
5:27 pm
Purchase
2023-04-1013GAthira Pharma, Inc.
ATHA
KAYNE RICHARD A1,983,668
5.300%
1,983,668increase
(New Position)
Filing